Advanced Search

Home Health & Hospice Week

Finance:

Public Companies Review Q1 In 'Year Of Disruption'

Published on Fri May 22, 2020

PPE, lower volume cost chains millions. 2020 was already expected to throw home health into chaos with the Patient-Driven Groupings Model, elimination or significant reduction of RAP payments, and more. Then came the pandemic. In recent days, heads of publicly traded home health and hospice companies recounted their coronavirus-related trials and successes throughout the first quarter of the year, often [...]
You’ve reached your limit of free articles. Already a subscriber? Log in.
Not a subscriber? Subscribe today to continue reading this article. Plus, you’ll get:
  • Simple explanations of current healthcare regulations and payer programs
  • Real-world reporting scenarios solved by our expert coders
  • Industry news, such as MAC and RAC activities, the OIG Work Plan, and CERT reports
  • Instant access to every article ever published in your eNewsletter
  • 6 annual AAPC-approved CEUs*
  • The latest updates for CPT®, ICD-10-CM, HCPCS Level II, NCCI edits, modifiers, compliance, technology, practice management, and more
*CEUs available with select eNewsletters.

Other Articles in this issue of

Home Health & Hospice Week

View All